Have a feature idea you'd love to see implemented?
Let us know!
PAVM PAVmed Inc
Price (delayed)
$1.01
Market cap
$11.18M
P/E Ratio
1.53
Dividend/share
N/A
EPS
$0.66
Enterprise value
$45.34M
PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital
Highlights
PAVmed's revenue has soared by 166% YoY and by 5% from the previous quarter
The net income has surged by 142% since the previous quarter and by 134% year-on-year
PAVM's quick ratio has dropped by 96% year-on-year and by 96% since the previous quarter
Key stats
What are the main financial stats of PAVM
Market
Valuations
Earnings
Shares outstanding
11.07M
Market cap
$11.18M
Enterprise value
$45.34M
Price to earnings (P/E)
1.53
Price to book (P/B)
N/A
Price to sales (P/S)
2.51
EV/EBIT
1.86
EV/EBITDA
1.73
EV/Sales
11.24
Revenue
$4.03M
EBIT
$24.38M
EBITDA
$26.25M
Free cash flow
-$45.76M
Per share
Balance sheet
Liquidity
EPS
$0.66
Free cash flow per share
-$4.57
Book value per share
-$0.47
Revenue per share
$0.4
TBVPS
$3.05
Total assets
$30.55M
Total liabilities
$39.94M
Debt
$34.93M
Equity
-$4.87M
Working capital
-$35.43M
Debt to equity
-7.17
Current ratio
0.06
Quick ratio
0.02
Net debt/EBITDA
1.3
Margins
Efficiency
Dividend
EBITDA margin
650.7%
Gross margin
-58.7%
Net margin
603%
Operating margin
-1,380.3%
Return on assets
41.9%
Return on equity
N/A
Return on invested capital
200.2%
Return on capital employed
N/A
Return on sales
604.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PAVM stock price
How has the PAVmed stock price performed over time
Intraday
-1.94%
1 week
-7.34%
1 month
-6.91%
1 year
-67.42%
YTD
-75.49%
QTD
-17.89%
Financial performance
How have PAVmed's revenue and profit performed over time
Revenue
$4.03M
Gross profit
-$2.37M
Operating income
-$55.68M
Net income
$24.32M
Gross margin
-58.7%
Net margin
603%
PAVmed's revenue has soared by 166% YoY and by 5% from the previous quarter
The net income has surged by 142% since the previous quarter and by 134% year-on-year
The net margin has soared by 140% from the previous quarter and by 113% YoY
PAVM's gross margin has surged by 82% year-on-year and by 24% since the previous quarter
Growth
What is PAVmed's growth rate over time
Valuation
What is PAVmed stock price valuation
P/E
1.53
P/B
N/A
P/S
2.51
EV/EBIT
1.86
EV/EBITDA
1.73
EV/Sales
11.24
The EPS has soared by 108% since the previous quarter and by 106% year-on-year
The equity has surged by 93% since the previous quarter and by 89% year-on-year
PAVmed's revenue has soared by 166% YoY and by 5% from the previous quarter
The stock's price to sales (P/S) is 57% less than its last 4 quarters average of 5.8
Efficiency
How efficient is PAVmed business performance
The ROS has soared by 140% since the previous quarter and by 113% year-on-year
PAVM's return on assets has surged by 132% year-on-year and by 124% since the previous quarter
The company's return on invested capital has surged by 128% YoY and by 127% QoQ
Dividends
What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PAVM.
Financial health
How did PAVmed financials performed over time
The total assets is 24% less than the total liabilities
PAVM's quick ratio has dropped by 96% year-on-year and by 96% since the previous quarter
PAVmed's current ratio has shrunk by 90% YoY and by 89% QoQ
The equity has surged by 93% since the previous quarter and by 89% year-on-year
The debt has contracted by 30% from the previous quarter and by 30% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.